518 related articles for article (PubMed ID: 9438143)
1. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
2. [A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood].
von Berg A; Berdel D
Monatsschr Kinderheilkd; 1993 Jan; 141(1):53-8. PubMed ID: 8095323
[TBL] [Abstract][Full Text] [Related]
3. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
5. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK; Jackson CM; Bates CE; Lipworth BJ
Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
[TBL] [Abstract][Full Text] [Related]
6. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
7. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
[TBL] [Abstract][Full Text] [Related]
8. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
[TBL] [Abstract][Full Text] [Related]
9. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of tolerance to beta-agonist bronchodilation.
Haney S; Hancox RJ
Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
Palmqvist M; Ibsen T; Mellén A; Lötvall J
Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
Bisgaard H
Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
[TBL] [Abstract][Full Text] [Related]
13. The duration of action of inhaled formoterol dry powder.
Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
[TBL] [Abstract][Full Text] [Related]
15. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
van Schayck CP; Cloosterman SG; Bijl-Hofland ID; van den Hoogen H; Folgering HT; van Weel C
Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta 2-agonists on histamine-induced airway microvascular leakage in ozone-exposed guinea pigs.
Inoue H; Aizawa H; Matsumoto K; Shigyo M; Takata S; Hara M; Hara N
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):723-7. PubMed ID: 9309985
[TBL] [Abstract][Full Text] [Related]
17. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
[TBL] [Abstract][Full Text] [Related]
18. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
Ulrik CS; Kok-Jensen A
Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma.
Nightingale JA; Rogers DF; Barnes PJ
Am J Respir Crit Care Med; 1999 Jun; 159(6):1786-90. PubMed ID: 10351919
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]